Kiviaq raises $980K to expand its dark store pharmacy model in Tokyo
What's the deal? Tokyo-based KiviaqDealroom has a profile for this one. Try Dealroom → has closed a pre-Series A round of US$1.15M (roughly $980,000), the pharmacy startup said. Mercuria InvestmentDealroom has a profile for this one. Try Dealroom →, Coral CapitalDealroom has a profile for this one. Try Dealroom →, and Spiral Innovation PartnersDealroom has a profile for this one. Try Dealroom → joined as new shareholders, bringing total funding since founding to US$2.15M.
What's the endgame? Kiviaq runs Kiviaq Pharmacy, applying the dark store model — popularised by grocery and daily-goods delivery — to prescription pharmacies. It promises online-only ordering with delivery in as little as 30 minutes, while keeping a staffed counter for in-person prescriptions and consultations.
Since opening its first location in Tokyo's Minato ward in October 2025, Kiviaq has linked up with 50 medical institutions and four online diagnosis platforms, and expanded same-day delivery to 18 wards across the city. Prescription volume has grown roughly tenfold since launch, with an 80% repeat rate in its self-delivery zones.
Why now? Japan's ageing population is driving up medical demand as staffing at clinics and pharmacies grows scarcer. Kiviaq cites its own research showing 90% of patients are dissatisfied with the traditional pharmacy experience, citing travel, wait times, stockouts, and privacy concerns.
What's the money for? The round funds a second pharmacy and system development. Kiviaq plans a "hub-and-spoke" network, with central dispensing sites handling inventory and bulk tasks so pharmacists at storefronts can focus on patient care.
The signal: Investors see medicine as the strongest candidate for quick delivery beyond food. Coral Capital noted Japan's insurance-dispensing market is worth about US$61.5B yet remains "highly fragmented," while Spiral Innovation Partners called it the "领域 most likely" to sustain quick commerce outside food — reframing the pharmacy as a logistics and supply-chain problem rather than a retail one.
Read more: prtimes.jp
Image credit: NavyMedicine
